Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 35 Lung Neoplasms 7 Small Cell Lung Carcinoma 2 Resectable Non-small Cell Lung Cancer 2 Neoplasms 2 Squamous-Cell Lung Cancer 1 Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Nonsquamous Non-small Cell Lung Cancer 1 Non-Squamous Non-Small Cell Lung Cancer 1 Neoplasm Metastasis 1 NSCLC 1 Melanoma 1 Lymphatic Metastasis 1 Esophageal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Bronchogenic 1 Carcinoma 1 Bronchial Neoplasms 1 Advanced Non-small Cell Lung Cancer 1 Advanced Non Small Cell Lung Cancer 1 Adenocarcinoma of Lung 1

Interventions

Platinum Compounds 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Squamous-Cell Lung Cancer × Platinum Compounds × Thoracic × Clear all

NCT03823625 2020-03-25

SQUINT

Fondazione Ricerca Traslazionale

Phase 2 Unknown

Squamous-Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡